ANNETTE KUBALEK: Open Payments
NPI 1376089334 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$43,799 in 267 payments from 19 companies in 2025. Trend: 2023 $4,358 · 2024 $6,861 · 2025 $43,799
Food & beverage: $23,634Speaker / faculty: $17,563Travel & lodging: $2,603
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 222 | $42,909 |
| Tandem Diabetes Care, Inc. | 13 | $197 |
| Amgen Inc. | 4 | $82 |
| Medtronic, Inc. | 4 | $79 |
| Ascendis Pharma Endocrinology Inc | 3 | $68 |
| Lilly USA, LLC | 3 | $61 |
| Mannkind Corporation | 1 | $46 |
| Averitas Pharma Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| CeQur Corporation | 1 | $42 |
Products named: FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, Yorvipath, MOUNJARO, AFREZZA, QUTENZA, CeQur Simplicity.
Industry payments across PA — which companies pay providers there.
